Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Operating loss at Schwarz Pharma narrowed in 2000

Article Abstract:

Schwarz Pharma AG narrowed its operating loss for the 2000 year. The company's operating loss was narrowed from 29.9 million euros in 1999 to 3.6 million euros in 2000.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
Germany, Schwarz Pharma AG

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Elan's revenue reaches $1 billion ahead of schedule

Article Abstract:

Elan posted $1 billion (1.01 billion euros) in revenues for the first time in 1999. The billion-dollar mark was achieved two years ahead of what Elan planned.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
Ireland, Elan Corporation PLC, ELN

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


AstraZeneca posts 6.4% rise in profit for third quarter

Article Abstract:

AstraZeneca PLC posted an increase of 6.4% in its profits for the 2001 third-quarter. The company posted $1.04 billion in pretax profits for the period.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
United Kingdom, Profit, Profits, AstraZeneca PLC, AZN

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry, Drugs, Finance
Similar abstracts:
  • Abstracts: Foster's says net rose 8.7% in year amid gains in U.S. Carlsberg sees rise of 71% in net profit for third period
  • Abstracts: Mediobanca warns of lower profit. Banca Intesa's profit fell 26% in 1st quarter on cost cutting
  • Abstracts: Merck's profit jumps 12% on 24% sales increase. AstraZeneca says it expects to meet annual forecast
  • Abstracts: The humbling of Amstrad. Alan Sugar shoots for the stars. The London street trader who would like to be as big as Sony
  • Abstracts: Doubles all round. Micromass: an instrumental role for senior debt
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.